West Pharma (WST) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $375.35 +0.89%
EPS Growth %: -34.3%
Financial Fact:
Net income: 37.6M
Today's EPS Names:
BVFL, MCET, REOS, More
EPS Growth %: -34.3%
Financial Fact:
Net income: 37.6M
Today's EPS Names:
BVFL, MCET, REOS, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q4 EPS of $0.54, $0.02 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $382.3 million versus the consensus estimate of $387.31 million.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Cadence Bancorporation (CADE) Tops Q1 EPS by 8c
- Bv Financial, Inc. (BVFL) Tops Q1 EPS by 24c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
